2026 Summer Intern – Corporate Affairs at Acadia Pharmaceuticals

Washington, District of Columbia, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biopharmaceutical, HealthcareIndustries

Requirements

Must be pursuing an undergraduate (Bachelor's) degree - major/interest in Political Science, International Affairs, Communications, External Affairs, Law, Policy (rising junior or rising senior preferred)
Proficient in Microsoft Office Suite
Strong knowledge of data management, pivot table creation, charts and bar graph creation, spreadsheet
Strong written and oral communicator
High degree of professionalism and interpersonal skills
Detail oriented
For Washington, D.C. Based Roles: Expected to work no less than 4 days at our office in Washington, D.C., on days in conjunction with your assigned team; may be able to work 1 day per week remotely
Ability to complete the entire 10-week program (from May 26, 2026 to July 31, 2026) and commit to 37.5 hours per week
Cumulative 3.0 GPA or above; college transcript required (must mail official transcript by application deadline to: Ferring Pharmaceuticals, Inc., Attn: Human Resources, Summer Intern Program, 100 Interpace Parkway, Parsippany, NJ 07054)
Currently enrolled in an accredited U.S. based college or university
Enrolled in either an undergraduate (Bachelor’s), graduate, MBA, JD, PharmD, or PhD program
Legally authorized to work in the U.S. without a need for sponsorship/CPT/OPT now or in the future
At least 18 years of age prior to the scheduled start date
Must be available to complete virtual interviews with HR and hiring manager
Must successfully pass a drug screen and background check prior to start date
Must complete a final presentation at the end of the 10-week program (mandatory)
Application deadline is January 9, 2026

Responsibilities

Engage with both government and non-government stakeholders, to include patient advocacy groups, key organizations and institutions in the international community and policy space
Participate in external networking/educational opportunities, strategy meetings and program development with key DC stakeholders and advocacy organizations
Assist with ongoing stakeholder mapping and the organization of data on key stakeholders
Develop policy, advocacy and other third-party meeting recap memorandums
Assist with ad hoc projects related to Corporate Affairs, to include research and data collection and analysis

Skills

Key technologies and capabilities for this role

Stakeholder EngagementPolicy AnalysisAdvocacyNetworkingStakeholder MappingProgram DevelopmentGovernment Relations

Questions & Answers

Common questions about this position

What is the location and remote work policy for this internship?

This role is based in Washington, D.C., requiring no less than 4 days per week in the office, with the option to work 1 day per week remotely.

What are the key requirements for this internship?

Candidates must be pursuing an undergraduate degree in Political Science, International Affairs, Communications, External Affairs, Law, or Policy (rising junior or senior preferred), be proficient in Microsoft Office Suite, have strong data management skills including pivot tables and charts, and possess strong written/oral communication, professionalism, interpersonal skills, and attention to detail.

What are the dates and time commitment for the internship?

The internship runs for 10 weeks from May 26, 2026 to July 31, 2026, requiring a commitment of 37.5 hours per week.

What is the compensation for this internship?

This information is not specified in the job description.

What is the company culture like at Ferring?

Ferring emphasizes a 'people first' philosophy, entrepreneurial spirit, long-term perspective, and commitment to science and research, and is recognized as Great Places to Work® Certified.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free